Silo Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
12 Jun 24 | BuyUS$5,533 | Eric Weisblum | Individual | 5,000 | US$1.11 | |
05 Apr 24 | BuyUS$1,988 | Eric Weisblum | Individual | 1,000 | US$2.03 | |
01 Apr 24 | BuyUS$8,713 | Eric Weisblum | Individual | 4,508 | US$1.94 | |
20 Dec 23 | BuyUS$1,137 | Eric Weisblum | Individual | 700 | US$1.63 | |
15 Dec 23 | BuyUS$1,668 | Eric Weisblum | Individual | 1,100 | US$1.52 | |
07 Dec 23 | BuyUS$1,376 | Eric Weisblum | Individual | 1,000 | US$1.39 | |
30 Nov 23 | BuyUS$3,100 | Eric Weisblum | Individual | 2,000 | US$1.57 | |
27 Nov 23 | BuyUS$1,117 | Eric Weisblum | Individual | 650 | US$1.78 | |
21 Nov 23 | BuyUS$6,948 | Eric Weisblum | Individual | 4,350 | US$1.60 | |
17 Nov 23 | BuyUS$4,235 | Eric Weisblum | Individual | 2,900 | US$1.54 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 0 | 0% |
Institutions | 95,636 | 2.13% |
Individual Insiders | 185,432 | 4.13% |
General Public | 4,203,388 | 93.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 44.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
180,432 | US$221.9k | 0% | no data | |||
41,848 | US$51.5k | 0% | no data | |||
16,334 | US$20.1k | 0% | no data | |||
16,179 | US$19.9k | 0% | no data | |||
12,500 | US$15.4k | 0% | no data | |||
6,663 | US$8.2k | 50.3% | no data | |||
5,000 | US$6.2k | 0% | no data | |||
2,000 | US$2.5k | 0% | no data | |||
94 | US$115.8 | 0% | no data | |||
17 | US$21.0 | 0% | no data | |||
1 | US$1.1 | 0% | no data |